Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor ...

Learn About the Latest Products and Upgrades that Accelerate Intelligent Solutions in Ion Implant BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies , Inc. (Nasdaq: ACLS ), a ...

Axcelis Technologies, Inc. ( NASDAQ: ACLS) Q4 2024 Earnings Call February 11, 2025 8:30 AM ET David Ryzhik - SVP, IR and Corporate Strategy Russell Low - President and CEO James Coogan - EVP and CFO ...

Revenue for Q4 2024 was $252 million, with earnings per diluted share of $1.54. The CEO highlighted strong demand in CS&I sales, which were the main driver of better-than-expected margins and EPS.

Learn About the Latest Products and Upgrades that Accelerate Intelligent Solutions in Ion Implant BEVERLY, Mass., Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading ...